Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Where do we go from here?

<< Previous

Bullboard Posts

Next >>

Comment by SironaInvestoron Oct 06, 2022 4:07am

212 Views

Post# 35008566

RE:RE:Where do we go from here?

Less pressure from the broader shareholder base. We can just hope that Antiaging testing starts soon with good results in Q1 2023. Pet deal is also promised from the CEO this year, but the same bullsh.it has been promised two years ago already. Maybe we get a bit of money in advance from Abbvie when they are the partner company for Antiaging.

<< Previous

Bullboard Posts

Next >>

AI companies to invest in